Gene symbol: C5

Also known as: Hc; C5a; RGD1561905

Organism: Rattus norvegicus

Summary: Enables C5a anaphylatoxin chemotactic receptor binding activity. Involved in several processes, including glucose homeostasis; leukocyte migration involved in inflammatory response; and negative regulation of catecholamine secretion. Located in extracellular space. Used to study adult respiratory distress syndrome; asthma; and neutropenia. Biomarker of brain edema. Human ortholog(s) of this gene implicated in several diseases, including complement component 5 deficiency; liver cirrhosis; neutropenia; paroxysmal nocturnal hemoglobinuria; and pneumonia. Orthologous to human C5 (complement C5). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 362119 Ensembl:ENSRNOG00000018899 AllianceGenome:RGD:2237


GO Annotation


Category Term ID Term description
Process GO:0001655 Urogenital system development
Process GO:0001701 In utero embryonic development
Process GO:0001776 Leukocyte homeostasis
Process GO:0001780 Neutrophil homeostasis
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001822 Kidney development
Process GO:0002250 Adaptive immune response
Process GO:0002252 Immune effector process
Process GO:0002253 Activation of immune response
Process GO:0002262 Myeloid cell homeostasis
Process GO:0002376 Immune system process
Process GO:0002443 Leukocyte mediated immunity
Process GO:0002449 Lymphocyte mediated immunity
Process GO:0002455 Humoral immune response mediated by circulating immunoglobulin
Process GO:0002460 Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002523 Leukocyte migration involved in inflammatory response
Process GO:0002682 Regulation of immune system process
Process GO:0002683 Negative regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002685 Regulation of leukocyte migration
Process GO:0002686 Negative regulation of leukocyte migration
Process GO:0002688 Regulation of leukocyte chemotaxis
Process GO:0002689 Negative regulation of leukocyte chemotaxis
Process GO:0006873 Cellular ion homeostasis
Process GO:0006874 Cellular calcium ion homeostasis
Process GO:0006875 Cellular metal ion homeostasis
Process GO:0006935 Chemotaxis
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006954 Inflammatory response
Process GO:0006955 Immune response
Process GO:0006956 Complement activation
Process GO:0006957 Complement activation, alternative pathway
Process GO:0006958 Complement activation, classical pathway
Process GO:0006959 Humoral immune response
Process GO:0007204 Positive regulation of cytosolic calcium ion concentration
Process GO:0007275 Multicellular organism development
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009611 Response to wounding
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009987 Cellular process
Process GO:0010466 Negative regulation of peptidase activity
Process GO:0010468 Regulation of gene expression
Process GO:0010574 Regulation of vascular endothelial growth factor production
Process GO:0010575 Positive regulation of vascular endothelial growth factor production
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010700 Negative regulation of norepinephrine secretion
Process GO:0010758 Regulation of macrophage chemotaxis
Process GO:0010760 Negative regulation of macrophage chemotaxis
Process GO:0010951 Negative regulation of endopeptidase activity
Process GO:0014059 Regulation of dopamine secretion
Process GO:0014061 Regulation of norepinephrine secretion
Process GO:0016064 Immunoglobulin mediated immune response
Process GO:0016477 Cell migration
Process GO:0019222 Regulation of metabolic process
Process GO:0019724 B cell mediated immunity
Process GO:0019725 Cellular homeostasis
Process GO:0019835 Cytolysis
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0030003 Cellular cation homeostasis
Process GO:0030162 Regulation of proteolysis
Process GO:0030334 Regulation of cell migration
Process GO:0030336 Negative regulation of cell migration
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032835 Glomerulus development
Process GO:0032879 Regulation of localization
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033602 Negative regulation of dopamine secretion
Process GO:0033604 Negative regulation of catecholamine secretion
Process GO:0040011 Locomotion
Process GO:0040012 Regulation of locomotion
Process GO:0040013 Negative regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042221 Response to chemical
Process GO:0042330 Taxis
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0043009 Chordate embryonic development
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043207 Response to external biotic stimulus
Process GO:0043269 Regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0044092 Negative regulation of molecular function
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045087 Innate immune response
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045861 Negative regulation of proteolysis
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048870 Cell motility
Process GO:0048872 Homeostasis of number of cells
Process GO:0048878 Chemical homeostasis
Process GO:0050433 Regulation of catecholamine secretion
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050801 Ion homeostasis
Process GO:0050896 Response to stimulus
Process GO:0050900 Leukocyte migration
Process GO:0050920 Regulation of chemotaxis
Process GO:0050921 Positive regulation of chemotaxis
Process GO:0050922 Negative regulation of chemotaxis
Process GO:0051046 Regulation of secretion
Process GO:0051048 Negative regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051094 Positive regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051707 Response to other organism
Process GO:0051952 Regulation of amine transport
Process GO:0051953 Negative regulation of amine transport
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0055065 Metal ion homeostasis
Process GO:0055074 Calcium ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0055082 Cellular chemical homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0072001 Renal system development
Process GO:0072006 Nephron development
Process GO:0072503 Cellular divalent inorganic cation homeostasis
Process GO:0072507 Divalent inorganic cation homeostasis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090594 Inflammatory response to wounding
Process GO:0097273 Creatinine homeostasis
Process GO:0098542 Defense response to other organism
Process GO:0098771 Inorganic ion homeostasis
Process GO:1901342 Regulation of vasculature development
Process GO:1903530 Regulation of secretion by cell
Process GO:1903531 Negative regulation of secretion by cell
Process GO:1904018 Positive regulation of vasculature development
Process GO:1905521 Regulation of macrophage migration
Process GO:1905522 Negative regulation of macrophage migration
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000146 Negative regulation of cell motility
Component GO:0005576 Extracellular region
Component GO:0005579 Membrane attack complex
Component GO:0005615 Extracellular space
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0032991 Protein-containing complex
Component GO:0046930 Pore complex
Component GO:0071944 Cell periphery
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0110165 Cellular anatomical entity
Function GO:0001664 G protein-coupled receptor binding
Function GO:0004857 Enzyme inhibitor activity
Function GO:0004866 Endopeptidase inhibitor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0030234 Enzyme regulator activity
Function GO:0030414 Peptidase inhibitor activity
Function GO:0031714 C5a anaphylatoxin chemotactic receptor binding
Function GO:0061134 Peptidase regulator activity
Function GO:0061135 Endopeptidase regulator activity
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
WikiPathways WP2433 Spinal cord injury
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04610 Complement and coagulation cascades
KEGG rno04613 Neutrophil extracellular trap formation
KEGG rno04810 Regulation of actin cytoskeleton
KEGG rno04936 Alcoholic liver disease
KEGG rno05020 Prion disease
KEGG rno05133 Pertussis
KEGG rno05150 Staphylococcus aureus infection
KEGG rno05168 Herpes simplex virus 1 infection
KEGG rno05171 Coronavirus disease - COVID-19
KEGG rno05322 Systemic lupus erythematosus

Expression profile of C5 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 4.2644987
GSM2685202 MX2 tissue: Myocardium gender: female 3.9609184
GSM2685203 MX3 tissue: Myocardium gender: female 4.5994506
GSM2685204 MX4 tissue: Myocardium gender: male 4.1812134
GSM2685205 DZ1 tissue: Myocardium gender: male 4.542303
GSM2685206 DZ2 tissue: Myocardium gender: male 4.6008987
GSM2685207 DZ3 tissue: Myocardium gender: female 4.274541
GSM2685208 DZ4 tissue: Myocardium gender: female 4.257958
GSM2685209 JJ1 tissue: Myocardium gender: male 4.549946
GSM2685210 JJ2 tissue: Myocardium gender: female 5.0963874
GSM2685211 JJ3 tissue: Myocardium gender: female 4.461265
GSM2685212 JJ4 tissue: Myocardium gender: male 4.4599295
GSM2685213 NG1 tissue: Myocardium gender: male 5.9051437
GSM2685214 NG2 tissue: Myocardium gender: female 4.1470304
GSM2685215 NG3 tissue: Myocardium gender: male 4.839599
GSM2685216 NG4 tissue: Myocardium gender: female 4.4329686
GSM2685217 YL1 tissue: Myocardium gender: male 4.3516073
GSM2685218 YL2 tissue: Myocardium gender: male 5.3903003
GSM2685219 YL3 tissue: Myocardium gender: female 4.6931686
GSM2685220 YL4 tissue: Myocardium gender: female 4.7997046
GSM2685221 QC1 tissue: Myocardium gender: male 4.8531923
GSM2685222 QC2 tissue: Myocardium gender: male 4.575076
GSM2685223 QC3 tissue: Myocardium gender: female 4.3191004
GSM2685224 QC4 tissue: Myocardium gender: female 4.349281

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.840143462
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.852951241
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.771573046
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.786045777
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.872961414
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 1.750187338

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 3.954015
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 4.23808
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 4.11619
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.412125
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.139254
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.01146

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.85082
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.61389
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.92355
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.89044
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.43537
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 11.65193
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 11.43752
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 11.71639
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 11.5863
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 11.66903
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 11.84601
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 11.55521
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 11.91783
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 11.85208
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 11.48482
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 11.66237
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.35313
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 11.63226
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 11.8665
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 11.85227
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 11.83181
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.05671
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 11.92893
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 11.90984
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 11.79556
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.44258
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.37001
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.38005
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.33857
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.62448
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.31483
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.05874
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.21603
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.29992
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.20885
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.15213
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.78958
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.99763
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.90836
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.70404
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 11.29389
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 11.49957
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 11.5991
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 11.40933
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 11.64217

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 126.20948999999999
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 124.07785

ID GSE245201
Title Transcriptional Reprogramming of Brain Cells Under Anesthesia in wt and Alzheimer's Disease mouse model
Organism Mus musculus
GSM Sample info Characteristics Value
GSM7847823 1_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847824 2_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847825 3_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847826 4_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847827 10_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847828 11_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847829 12_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847830 13_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847831 14_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847832 15_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847833 16_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847834 17_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847835 18_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847836 19_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847837 20_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847838 25_APP/PS1_Ketamine tissue: Hippocampus genotype: APP/PS1 treatment: Ketamine
GSM7847839 26_APP/PS1_Ketamine tissue: Hippocampus genotype: APP/PS1 treatment: Ketamine
GSM7847840 27_WT_Ketamine tissue: Hippocampus genotype: WT treatment: Ketamine
GSM7847841 28_WT_Ketamine tissue: Hippocampus genotype: WT treatment: Ketamine
GSM7847842 29_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake

ID GSE245201
Title Transcriptional Reprogramming of Brain Cells Under Anesthesia in wt and Alzheimer's Disease mouse model
Organism Mus musculus
GSM Sample info Characteristics Value
GSM7847823 1_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847824 2_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847825 3_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847826 4_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847827 10_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847828 11_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847829 12_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847830 13_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847831 14_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847832 15_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847833 16_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847834 17_APP/PS1_Wake tissue: Hippocampus genotype: APP/PS1 treatment: Wake
GSM7847835 18_WT_Isofluran tissue: Hippocampus genotype: WT treatment: Isofluran
GSM7847836 19_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake
GSM7847837 20_APP/PS1_Isofluran tissue: Hippocampus genotype: APP/PS1 treatment: Isofluran
GSM7847838 25_APP/PS1_Ketamine tissue: Hippocampus genotype: APP/PS1 treatment: Ketamine
GSM7847839 26_APP/PS1_Ketamine tissue: Hippocampus genotype: APP/PS1 treatment: Ketamine
GSM7847840 27_WT_Ketamine tissue: Hippocampus genotype: WT treatment: Ketamine
GSM7847841 28_WT_Ketamine tissue: Hippocampus genotype: WT treatment: Ketamine
GSM7847842 29_WT_Wake tissue: Hippocampus genotype: WT treatment: Wake